Since the MYC‐driven increase in transcription overloads proper pre‐mRNA splicing, the depletion or pharmacological inhibition of core spliceosome components, including SF3B1, is detrimental for MYC‐dependent cancer cells.10 The gene discussed is SF3B1; the disease is cancer.